Fundraising Fox

Kate Therapeutics

San Diego, US · Founded 2020 · Delaware corporation · 1 known investors

Biotechin /novartis@novartis

Founders & leadership

KF
Kevin Forrest, Ph.D.Executive Officer, Director
CO
Clare Ozawa, Ph.D.Director
BS
Beth Seidenberg, M.D.Director

Investors · 1

Westlake Village BioPartnersLos Angeles · $100K – $5M

Reported raises · per SEC filings

Form D private placements
▶$16MraisedAug 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Clare Ozawa, Ph.D.Director
  • Kevin Forrest, Ph.D.Executive Officer, Director
  • Beth Seidenberg, M.D.Director
Offering amount
$16M
Amount sold
$16M
First sale
Feb 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$21.8MraisedAug 2024 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Clare Ozawa, Ph.D.Director
  • Kevin Forrest, Ph.D.Executive Officer, Director
  • Beth Seidenberg, M.D.Director
Offering amount
$23.4M
Amount sold
$21.8M
First sale
May 2024
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$35MraisedAug 2024 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin Forrest, Ph.D.Executive Officer, Director
  • Clare Ozawa, Ph.D.Director
  • Beth Seidenberg, M.D.Director
Offering amount
$35M
Amount sold
$35M
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.